ES2055440T3 - Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen. - Google Patents

Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2055440T3
ES2055440T3 ES90912563T ES90912563T ES2055440T3 ES 2055440 T3 ES2055440 T3 ES 2055440T3 ES 90912563 T ES90912563 T ES 90912563T ES 90912563 T ES90912563 T ES 90912563T ES 2055440 T3 ES2055440 T3 ES 2055440T3
Authority
ES
Spain
Prior art keywords
chinurene
derivatives
contain
preparation
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90912563T
Other languages
English (en)
Inventor
Flavio Moroni
Roberto Pellicciari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Application granted granted Critical
Publication of ES2055440T3 publication Critical patent/ES2055440T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

LOS COMPUESTOS DE LA FORMULA (I) (R, R SUB 1, R SUB 2, R SUB 3 Y R SUB 4 SON COMO DEFINEN EN LA ESPECIFICACION) SON UTILES COMO AGENTES TERAPEUTICOS PARA EL TRATAMIENTO DE LAS PATOLOGIAS DEL SISTEMA NERVIOSO CENTRAL.
ES90912563T 1989-08-11 1990-08-07 Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2055440T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8921512A IT1232352B (it) 1989-08-11 1989-08-11 Derivati dell'acido chinurenico ad attivita' sul sistema nervoso centrale, loro preparazione e relative composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
ES2055440T3 true ES2055440T3 (es) 1994-08-16

Family

ID=11182908

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90912563T Expired - Lifetime ES2055440T3 (es) 1989-08-11 1990-08-07 Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.

Country Status (15)

Country Link
US (1) US5250541A (es)
EP (1) EP0486586B1 (es)
JP (1) JPH05500362A (es)
KR (1) KR927003536A (es)
AT (1) ATE106874T1 (es)
AU (1) AU635063B2 (es)
CA (1) CA2064566A1 (es)
DE (1) DE69009765T2 (es)
DK (1) DK0486586T3 (es)
ES (1) ES2055440T3 (es)
FI (1) FI94631C (es)
HU (1) HUT64525A (es)
IT (1) IT1232352B (es)
NO (1) NO178622C (es)
WO (1) WO1991001973A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5493027A (en) * 1993-01-22 1996-02-20 Board Of Regents, The University Of Texas System Anticonvulsive agents and uses thereof
US5783700A (en) * 1997-07-03 1998-07-21 Nichols; Alfred C. Quinolic acid derivatives
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
CN102600154B (zh) * 2012-01-20 2014-11-26 北京大学 7-氯代硫犬尿酸在制备预防和/或治疗单相抑郁症的药物中的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719102D0 (en) * 1987-08-12 1987-09-16 Merck Sharp & Dohme Therapeutic agents
US5114939A (en) * 1988-01-29 1992-05-19 Dowelanco Substituted quinolines and cinnolines as fungicides

Also Published As

Publication number Publication date
ATE106874T1 (de) 1994-06-15
DE69009765D1 (de) 1994-07-14
HUT64525A (en) 1994-01-28
US5250541A (en) 1993-10-05
NO178622C (no) 1996-05-02
NO920524D0 (no) 1992-02-10
NO920524L (no) 1992-02-10
KR927003536A (ko) 1992-12-18
NO178622B (no) 1996-01-22
DK0486586T3 (da) 1994-10-24
AU635063B2 (en) 1993-03-11
AU6177790A (en) 1991-03-11
DE69009765T2 (de) 1994-11-24
IT1232352B (it) 1992-01-28
JPH05500362A (ja) 1993-01-28
EP0486586A1 (en) 1992-05-27
FI94631C (fi) 1995-10-10
WO1991001973A1 (en) 1991-02-21
FI920553A0 (fi) 1992-02-10
EP0486586B1 (en) 1994-06-08
FI94631B (fi) 1995-06-30
IT8921512A0 (it) 1989-08-11
CA2064566A1 (en) 1991-02-12
HU9200400D0 (en) 1992-06-29

Similar Documents

Publication Publication Date Title
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
MX9704777A (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen.
AR001332A1 (es) Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2097341T3 (es) Indoles sustituidos como farmacos para el tratamiento del sida.
ES2119124T3 (es) Bencimidazoles utiles para el tratamiento de trastornos del sistema nervioso.
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
ES2084944T3 (es) Amidas terapeuticas.
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ECSP941122A (es) Derivados de 5-arilindoles
CO4290424A1 (es) Pirazolopiridinas, pirrolopiridinas, composiciones farmaceu- ticas que las contienen y procedimientos para su administra- cion como antagonista del factor de liberacion de cortico- tropina
ES2147759T3 (es) Heterociclos no aromaticos sustituidos con aminometileno y uso como antagonistas de la sustancia p.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2072323T3 (es) Compuestos de piperidina y su preparacion y empleo.
ES2118283T3 (es) Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos.
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES2054872T3 (es) Nuevos derivados de acido bencimidazolin-2-oxo-1-carboxilico utiles como antagonistas de los receptores 5-ht.
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ES2086579T3 (es) Antagonista de leucotrieno b4.
MX9400070A (es) Compuestos heterociclicos, un procedimiento para prepararlos, su uso y composiciones farmaceuticas que los contienen.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 486586

Country of ref document: ES